publication venue for

• Abilities of -Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells.  75. 2020
• Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells.  71:172-182. 2019
• Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells 2019
• Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals.  72:22-40. 2019
• Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells-Power of nutraceuticals.  67:190-211. 2018
• Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals.  69:16-34. 2018
• Metformin influences drug sensitivity in pancreatic cancer cells 2018